Small Molecule CDMOs

SGS

Brazil

SGS Integrated CDMO Solutions is the contract development and manufacturing division of the global testing and inspection company SGS SA. Established in 2002 with a specialized UK-based CDMO site (MHRA and FDA inspected), SGS provides formulation development, API manufacturing, sterile fill/finish, lyophilization, and analytical services. A new 55,000 sq ft cGMP facility in Hudson, NH expands their North American capabilities across Phase I-III clinical trials and commercial supply.

SIDEFARMA

Portugal

SIDEFARMA is a Portuguese CMO with over 45 years of experience, specialized in the manufacture of small and medium-size batches of solid dosage forms (coated tablets, tablets, capsules), semi-solids (creams, gels, ointments), and liquid pharmaceuticals. The company provides contract manufacturing, contract packaging, and contract development services following European quality standards, while also commercializing its own branded pharmaceutical products.

Siegfried Group

China

Siegfried Group is a leading global CDMO with 150+ years of pharmaceutical and chemical heritage, operating 13 production sites across Switzerland, Germany, Spain, France, Malta, the USA, and China. The company provides integrated services from early-phase API development through commercial-scale drug substance and drug product manufacturing, including exclusive synthesis, generic APIs, controlled substances, HPAPI handling, sterile formulations, and viral vector manufacturing through subsidiary DINAMIQS. In January 2026, Siegfried announced acquisition of additional US-based small molecule drug substance capacity.

Sinoway Industrial Co., Ltd.

China

Sinoway Industrial Co., Ltd., established in 1987 in Xiamen, China, is a pharmaceutical company specializing in custom development, custom manufacturing, and trading of APIs, pharmaceutical intermediates, polypeptides, prostaglandin series, cosmetic raw materials, herbal extracts, health & food supplements, and finished dosage forms (FDF). They provide one-stop CDMO services from R&D to production. With over 30 years of pharmaceutical export experience serving Europe, North America, Middle East, Japan, and Korea, Sinoway positions itself as both a CDMO and trading company.

SmaBio Labs

United States

SmaBio Labs is a USA-based CDMO located in Research Triangle Park, North Carolina, delivering end-to-end drug development solutions from molecule discovery to market launch. They specialize in Chemistry Manufacturing and Control (CMC) services for small molecules, peptides, biologics, and complex APIs. Their capabilities include analytical services (IND/ANDA support, method development and validation, ICH stability testing, HPLC/UPLC, LC-MS, ICP-MS, NMR, XRPD), drug discovery and process development, API manufacturing (kg-scale cGMP), product development (formulation for oral solid dose, injectables, lyophilized products), and clinical trial material manufacturing (Phase I-III). FDA registered for analytical services. They support HPAPI compounds up to OEB 5.

Softgel Healthcare Pvt Ltd

India

Softgel Healthcare Pvt Ltd is an Indian CDMO with over 18 years of expertise in formulating, developing, and manufacturing soft gelatin capsules. Operating USFDA and EU-GMP approved facilities, the company serves over 100 partners in 60+ countries. Key products include Enzalutamide, Cyclosporine, Tafamidis, Nintedanib, and other complex softgel formulations. The company was acquired by Everstone Capital.

Special Product’s Line – CDMO Services

Italy

Special Product's Line (SPL) is an Italian CDMO founded in 1978, specializing in the production of non-sterile pharmaceutical products. The company operates a 50,000 sqm state-of-the-art facility with over 500 employees, serving more than 60 international pharmaceutical companies. SPL offers full-service CDMO capabilities from development to production and registration across a wide range of dosage forms including tablets, capsules, powders, oral liquids, creams, suppositories, ovules, and softgel capsules.

Sunsho Pharmaceutical Co., Ltd.

Japan

Sunsho Pharmaceutical Co., Ltd. is Japan's leading contract manufacturing pharmaceutical company, operating as a CDMO across three business verticals: health food (supplements), new applications (flavor capsules), and pharmaceuticals (generic drugs). The company specializes in capsule and formulation technologies, with the Nanryo Factory being one of the largest soft capsule manufacturing plants in Japan.

Synokem Pharmaceuticals Ltd

India

Synokem Pharmaceuticals Ltd is one of India's largest CDMOs, backed by TA Associates investment (2023). The company specializes in contract development and manufacturing, ethical marketing, and pharmaceutical exports. Synokem acquired Nitin Lifesciences Ltd and Parabolic Drugs Ltd to expand API production capacity. The company recently launched a modernized cephalosporin injectable manufacturing block for commercial production. Synokem's website is currently suspended but the company remains operational and expanding.

Tedor Pharma Inc

United States

Tedor Pharma is a US-based CDMO with 20+ years of experience specializing in solid oral dosage forms. Located in Cumberland, Rhode Island, they provide end-to-end outsourcing from IND/NDA/ANDA through commercial manufacture. Services include formulation development, clinical trial manufacturing (including placebo), commercial GMP manufacturing at various scales, analytical services (characterization, testing, development, QA), and clinical supply chain management. FDA-registered and inspected (5 inspections, all VAI), DEA-licensed for controlled substances Schedules II-V. They have 2 FDA-approved products (tablets, oral route). The company announced a recapitalization and new management.

The Vanguard Utility Corporation

United States

US-based company using next-generation Blow-Fill-Seal equipment and prefabricated robotic packaging lines to fill-finish generic injectable medicines. Operational subsidiary of ApiJect. Two business approaches: (1) producing compounded pharmaceutical products for the US market through its Global Pharmacy Reserve division, and (2) licensing prefabricated fill-finish lines with their technology to pharma companies globally (Pharmaceutical Reserve Network). Focused on addressing drug shortages of generic injectables. Headquartered in Stamford, CT with operations in Newtown, PA. FDA-registered with 1 NAI inspection.

Titan Laboratories Pvt Ltd

India

Titan Laboratories Pvt Ltd is an integrated Indian pharmaceutical company and the first Indian pellet company to receive EU-GMP Written Confirmation. Established in 2004, it manufactures and exports pharmaceuticals and APIs across 47 countries, with specialization in pellets, granules, tablets, capsules, and creams/ointments. The company holds EU-GMP, TGA, ANVISA, WHO-GMP, MFDS, and other international approvals.

Tosca Pharmachem (Tosco Pharmachem Pvt Ltd)

India

Tosco Pharmachem Pvt Ltd is an Indian pharmaceutical contract manufacturing company providing third-party/contract manufacturing services for formulated pharmaceutical products. The company's website has been compromised by spam, but search results confirm it operates as a CMO offering pharmaceutical manufacturing across multiple dosage forms including tablets, capsules, liquids, and topicals.

Trident Lifeline Limited

India

Trident Lifeline Limited is an Indian pharmaceutical company established in 2014, engaged in manufacturing and marketing finished dosage forms. The company offers contract manufacturing services (hybrid model: own products + third-party manufacturing) for tablets, capsules, dry powder, liquid, ointment, gel, and injectable products. WHO-GMP compliant with global presence in 40+ countries. 3133+ products registered with India FDA, 989+ globally registered products.

UniD Manufacturing

Belgium

UniD Manufacturing is a Belgian CDMO fully dedicated to polymer-based long-acting formulations for sustained release and local delivery of drugs. They offer end-to-end services from proof of concept to commercialization, specializing in non-biodegradable (up to 9 years release), biodegradable (3-18 months), and resorbable (1 day to 3 months) polymer technology platforms. Applications include vaginal rings, ophthalmic implants, inserts, and other implantable dosage forms. They have 20+ years of expertise and GMP-approved cleanrooms accredited for multi-product manufacturing, with required facilities for high-potent APIs (hormones, peptides).

Unilab Chemicals & Pharmaceuticals Pvt Ltd

India

Unilab Chemicals & Pharmaceuticals Pvt Ltd is an Indian manufacturer of Active Pharmaceutical Ingredients (APIs), bulk drugs, and finished dosage forms, established in 1978 near Mumbai. Their product portfolio focuses heavily on antiseptic and disinfectant APIs and formulations including Chlorhexidine Gluconate, Povidone Iodine, Cetrimide, Benzalkonium Chloride, and related topical/liquid formulations. They also manufacture APIs like Guaifenesin, Phenothiazine, and other pharmaceutical chemicals.

Valpharma Group

San Marino

Valpharma Group is a pharmaceutical and nutraceutical CDMO based in San Marino with 40+ years of experience. The group consists of Valpharma San Marino S.p.A. and Valpharma International S.p.A. (two CDMO pharmaceutical companies) plus Erba Vita Group S.p.A. (nutraceuticals). They specialize in modified-release products in capsules and tablets, including narcotic and psychotropic substances. Services include contract manufacturing, tech transfer, regulatory and e-CTD management, pharmaceutical development, stability studies, and IMP (investigational medicinal product) batch production. They operate three production plants and are routinely audited by Italian Health Authorities for GMP compliance. Products sold in 70+ countries.

Vefa İlaç San. ve Tic. A.Ş.

Turkey

Vefa Ilac San. ve Tic. A.S. is a Turkish pharmaceutical manufacturer based in Beylikduzu, Istanbul, established in 2012 with GMP certification obtained in 2013. They manufacture pharmaceuticals, traditional herbal medicines, food supplements, and personal care products for both domestic and export markets. They have significant production capacity: 902 million tablets/year, 270 million capsules/year, 252 million coated units/year, 48 million bottles/year, and 15 million cream & gel units/year. Products are exported to Azerbaijan, Georgia, Ukraine, Iraq, Yemen, Saudi Arabia, and Romania. They hold WHO GMP and ISO 9001:2015 certifications. Their vision focuses on becoming a leading private label (contract) production base in Eurasia for pharmaceutical and nutraceutical products.

Vianex S.A.

Greece

Vianex S.A. is a prominent Greek pharmaceutical company listed on PharmaSource as a CDMO. The company is described as specializing in contract development and manufacturing. While the website content is primarily in Greek and could not be fully parsed, PharmaSource confirms CDMO services. The company appears to have multiple manufacturing facilities (Factory A, B, C, D mentioned in navigation) and covers a broad range of dosage forms. Founded by Paul J. Giannacopoulos.

West Coast Pharmaceutical Works Ltd

India

West Coast Pharmaceutical Works Ltd is an Indian manufacturer of pharmaceutical formulations primarily for human and veterinary use. The company also produces nutraceutical products. West Coast is FDA-registered and operates contract manufacturing services for pharmaceutical formulations.

Wiewelhove

Germany

Wiewelhove GmbH is a German contract manufacturer specializing exclusively in solid dosage forms. The company provides galenic development, wet granulation, compaction, blending, tabletting, capsule filling, film coating, sugar coating, bottling, blistering, and packaging services. Wiewelhove positions itself as a reliable partner for all aspects of contract manufacturing of solid dosage forms.

Xedev

Belgium

Xedev is a flexible CDMO based in Belgium, specialized in formulation and process development for oral solid dosage forms. They offer early-phase development services including spray drying, hot melt extrusion, amorphous solid dispersions, and GMP clinical manufacturing for Phase I and Phase II batches.

ABC Farmaceutici, an ICE Pharma company, is an Italian CDMO established in 1925 specializing in oral solid and liquid formulation manufacturing. Their 76,000 sqm facility in Ivrea (near Turin) is fully GMP certified and regularly inspected by AIFA and FDA. As part of ICE Pharma, they manage the entire drug supply chain from API through finished dosage form manufacturing.

AMW (AMW GmbH)

Germany

AMW GmbH is a specialty pharmaceutical CDMO based in Warngau, Germany, specializing in biodegradable implant formulations using hot melt extrusion technology. The company offers contract development and manufacturing of implant drug products with biotechnological active ingredients, operating under EU-GMP with capabilities spanning development, analytics, manufacturing, and regulatory affairs.

Anhui Biochem Pharmaceutical (ABUP) is a Chinese pharmaceutical company manufacturing APIs, intermediates, and finished dosage forms, with a focus on antiviral drugs (AIDS and hepatitis) and Parkinson's disease medications. They also offer customized processing (contract manufacturing) services.

Bushu Pharma is Japan's premier CDMO with over 25 years of experience, specializing in contract manufacturing of solid dosage formulations, sterile injectables, lyophilized products, and prefilled syringes for both clinical trial supplies and commercial products. The company operates five factories in Japan with GMP certifications from 56 countries including FDA, EMA, and PMDA, serving over 90 pharmaceutical companies globally with nearly 50% of sales from foreign-affiliated clients.

Caplin Point Laboratories is a fully integrated Indian pharmaceutical company with a dominant presence in Latin America and Francophone Africa, and a growing presence in the US and EU. Through its subsidiary Caplin Steriles, the company manufactures sterile injectables, ophthalmic products, pre-mix bags, and pre-filled syringes, with 46 FDA-approved products.

Cenra Pharma (formerly CCPC, China Chemical & Pharmaceutical Co.) is a Taiwanese pharmaceutical company established in 1952 that develops and manufactures APIs and generic drugs, also providing CMO/CDMO services. The company has FDA and PMDA facility approvals, PIC/S GMP compliance, and offers services from API selection through formulation development and commercial manufacturing. Cenra specializes in high-potency drugs including immunosuppressants and oncology drugs, with dedicated production lines for penicillins, cephalosporins, carbapenems, and immunosuppressants.

Clearsynth

Canada

Clearsynth is a technology-based research-driven enterprise headquartered in Mumbai with operations in Canada, US, Europe, and India. The company offers CDMO services for small molecule manufacturing from milligram to multi-tonne scale under GMP conditions, along with reference standards, stable isotope labeled compounds, contract R&D synthesis, process development, and analytical services including BIO NMR at its 50,000+ sq ft R&D facility in Hyderabad.

CordenPharma is a full-service CDMO providing integrated development and manufacturing of APIs, drug products, and lipid excipients across a global network of cGMP facilities in Europe and North America. The company offers capabilities spanning peptides, oligonucleotides, highly potent and oncology compounds, small molecules, injectables, lipid nanoparticles (LNPs), and oral solid dosage forms. CordenPharma is investing over EUR 500M in a new peptide manufacturing facility in Muttenz, Switzerland, and expanding its Colorado site for large-scale peptide production.

Dishman Carbogen Amcis Ltd

China

Dishman Carbogen Amcis Ltd is a global CDMO and pharmaceutical outsourcing partner with operations across India, Switzerland, UK, France, Netherlands, and China. With 30 years of experience, they offer custom API development and manufacturing up to 100 metric ton scale, drug product capabilities including highly potent compounds and ADCs, plus finished dosage forms including soft gel capsules and encapsulation. They have received successful USFDA, PMDA, and EDQM inspections.

Domixtar Pharmaceuticals SpA

Italy

Domixtar Pharmaceuticals (DMX Pharma) is Italy's largest CDMO, formed from the merger of Doppel Farmaceutici and Mipharm, and part of the group that includes Alfa Omega for nutraceuticals. With 1,000 professionals serving 105 partners across 30 countries, they offer full-service outsourcing from formulation development through post-marketing, including production, packaging, R&D, logistics, and quality control for pharmaceutical products.

Douglas CDMO

United Kingdom

Douglas CDMO is a division of Douglas Healthcare, an established pharmaceutical company headquartered in New Zealand with a world-class reputation for high standards. The company offers integrated contract development and manufacturing services specializing in high-potency softgels for pharma, biotech, and life science firms.

Eromol UK Ltd (Eramol)

United Kingdom

Eramol (formerly Eromol UK Ltd) is a UK-based CDMO specializing in bespoke clinical trial manufacturing services, founded by two Qualified Persons. The company provides end-to-end services including formulation development, primary manufacturing, clinical packaging, QP release, and global distribution from MHRA and HPRA-approved facilities, with a new sterile injectable site opening in early 2026.

Eskag Global Division (Eskag Pharma)

India

Eskag Pharma is an Indian pharmaceutical manufacturer offering third-party and contract manufacturing services for pharmaceuticals, nutraceuticals, and liposomal products. Founded in 1977, the company has 47+ years of experience and markets 39+ products across 50+ cities with 183 formulations and 50+ DGGI-approved molecules.

Eurofins Biopharma Services (CDMO)

Australia

Eurofins Biopharma Services CDMO is a division of Eurofins Scientific offering integrated API and drug product outsourcing services across small molecules and biologics. The company provides services from early-stage development through commercial manufacturing including highly potent drug development, sterile manufacturing/fill-finish, lyophilization, and biologics development through its Alphora brand.

European Medical Contract Manufacturing (EMCM)

Netherlands

European Medical Contract Manufacturing (EMCM) is a Dutch full-service contract manufacturer and centre of excellence in developing and manufacturing sterile medicinal products for the pharmaceutical and medical device markets. The company has 2000m2 of GMP-accredited facilities with cleanrooms from class D to class A, handling liquids, suspensions, gels, and powders in ampoules, vials, pre-filled syringes, and pouches.

EUROPHARTECH

France

EUROPHARTECH (Domes Pharma Manufacturing) is a French GMP-certified CMO (Contract Manufacturing Organisation) specializing in the production of small and medium batch pharmaceutical and veterinary products. The company offers oral solid dosage forms (tablets, capsules, powders) and non-sterile liquids for both human and veterinary markets, with a 500m2 QC laboratory equipped with HPLC, UV-visible, IR, and Karl Fischer analyzers.

Evonik Industries AG

Canada

Evonik Industries AG is a global specialty chemicals company that operates as a leading CDMO for complex parenteral drug products, focusing on polymeric and lipid-based delivery systems including liposomes, nanoparticles, microparticles, implants, and LNP formulations. The company's Health Care division provides end-to-end CDMO services for small molecules, peptides, nucleic acids (mRNA, siRNA), and HPAPIs, with FDA-inspected facilities in the US and Canada and 34 FDA inspections with zero OAI outcomes.

Exemed Pharmaceuticals

India

Exemed Pharmaceuticals is an Indian pharmaceutical company established in 2009, with US FDA, EDQM, and EU GMP certified manufacturing facilities in Vadodara and Vapi, Gujarat. The company manufactures APIs including Metformin HCL, Allopurinol, Levetiracetam, and Vildagliptin, and also has a finished formulation manufacturing facility acquired from UCB India.

FAMAR

Greece

FAMAR is a leading European pharmaceutical CDMO headquartered in Greece with a network of 7 production sites and 2 R&D centers across Europe, employing approximately 1,800 people. The company provides development, manufacturing, quality, regulatory, and logistics services for a wide range of pharmaceutical and consumer care products across 80+ international markets, with capabilities spanning from oral solid dose to sterile injectables and HPAPI products.

Fareva

Brazil

Fareva is a family-owned French CDMO and the largest in France, employing 13,000 people across 41 production sites in 13 countries with EUR 2.22 billion revenue in 2025. The company provides comprehensive pharmaceutical subcontracting from API manufacturing (including HPAPIs, cytotoxics, hormones, steroids, and controlled substances) to finished drug product manufacturing and packaging across oral, sterile injectable, nasal, ophthalmic, and semi-solid dosage forms.

FarmaTek

Turkey

FarmaTek (Farmatek Ilac San ve Tic A.S.) is a Turkish pharmaceutical company founded in 1991 that transitioned from drug importing to manufacturing, incorporating a hybrid business model including CDMO services. The company operates a GMP-approved production facility in Kirklareli Organized Industrial Zone (approved 2017) and received EU GMP certification in 2021.

Fermion, a wholly owned subsidiary of Orion Corporation (Finland), is a CDMO specializing in developing, manufacturing, and marketing small molecule Active Pharmaceutical Ingredients (APIs), including HPAPIs, cytotoxics, steroids, generics, and controlled substances. Together with its parent Orion, it offers integrated contract development and manufacturing services for both drug substances and drug products, covering the full lifecycle from preclinical to commercial scale. FDA-approved since 1979 and EMA-approved since 1971.

Formulated Solutions

United States

Formulated Solutions is a U.S.-based CDMO providing formulation development, analytical development, manufacturing, regulatory affairs, and packaging services for pharmaceutical and consumer health products. The company offers flexible manufacturing from small-scale clinical batches to large-scale commercial production across multiple dosage forms.

Gaelic Laboratories Limited

Ireland

Gaelic Laboratories Limited is an Irish contract manufacturer specializing in Beta-Lactam (penicillin) products in tablet, capsule, and powder for suspension form. Established in 2022 on a site with 40 years of FDA-approved Beta-Lactam manufacturing history, the company serves EU, UK, and MENA markets. The facility spans 8,000 sqm across two GMP manufacturing plants on an 11-acre site, with HPRA licensing.

Galentic Pharma (India) Pvt Ltd

India

Galentic Pharma (India) Pvt Ltd is an Indian contract manufacturer established in 1992, specializing in sterile ophthalmic products and non-sterile dermatological products. The company operates two US FDA cGMP compliant and WHO-GMP approved manufacturing facilities with both aseptic and non-sterile capabilities. Galentic exports over 80 products to multiple countries including ophthalmic ointments/gels and a diverse range of derma topicals.

GENSENTA

Turkey

Gensenta (formerly Mustafa Nevzat Ilac, acquired by Amgen in 2012 and sold to Eczacibasi in 2020) is a vertically integrated Turkish pharmaceutical company with two manufacturing facilities in Yenibosna and Sekerpinar, Turkey. The company manufactures both drug products and raw materials (APIs), and has been recognized in the sterile injectable CDMO market. Gensenta is listed as part of the Eczacibasi group and produces pharmaceuticals including caspofungin.